Compounds > celastrol methyl ester
Page last updated: 2024-09-04

celastrol methyl ester and N-(4-Butan-2-ylphenyl)-N-[2-(cyclopentylamino)-2-oxo-1-pyridin-3-ylethyl]furan-2-carboxamide

celastrol methyl ester has been researched along with N-(4-Butan-2-ylphenyl)-N-[2-(cyclopentylamino)-2-oxo-1-pyridin-3-ylethyl]furan-2-carboxamide in 1 studies

Compound Research Comparison

Studies
(celastrol methyl ester)		Trials
(celastrol methyl ester)		Recent Studies (post-2010)
(celastrol methyl ester)		Studies
(N-(4-Butan-2-ylphenyl)-N-[2-(cyclopentylamino)-2-oxo-1-pyridin-3-ylethyl]furan-2-carboxamide)		Trials
(N-(4-Butan-2-ylphenyl)-N-[2-(cyclopentylamino)-2-oxo-1-pyridin-3-ylethyl]furan-2-carboxamide)		Recent Studies (post-2010) (N-(4-Butan-2-ylphenyl)-N-[2-(cyclopentylamino)-2-oxo-1-pyridin-3-ylethyl]furan-2-carboxamide)
39027904

Protein Interaction Comparison

ProteinTaxonomycelastrol methyl ester (IC50)N-(4-Butan-2-ylphenyl)-N-[2-(cyclopentylamino)-2-oxo-1-pyridin-3-ylethyl]furan-2-carboxamide (IC50)
3C-like protease, partialInfectious bronchitis virus2.227
Spike glycoproteinBetacoronavirus England 12.2
Replicase polyprotein 1abBetacoronavirus England 12.2
Transmembrane protease serine 2Homo sapiens (human)2.2
Procathepsin LHomo sapiens (human)2.2
Replicase polyprotein 1aSevere acute respiratory syndrome-related coronavirus2.2
Replicase polyprotein 1abHuman coronavirus 229E2.2
Replicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus2.2
Replicase polyprotein 1abSevere acute respiratory syndrome coronavirus 22.2
Spike glycoproteinSevere acute respiratory syndrome-related coronavirus2.2
Angiotensin-converting enzyme 2 Homo sapiens (human)2.2

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Chen, J; Gao, K; Huang, F; Tepe, JJ; Wang, R; Wei, GW1

Other Studies

1 other study(ies) available for celastrol methyl ester and N-(4-Butan-2-ylphenyl)-N-[2-(cyclopentylamino)-2-oxo-1-pyridin-3-ylethyl]furan-2-carboxamide

ArticleYear
Perspectives on SARS-CoV-2 Main Protease Inhibitors.
    Journal of medicinal chemistry, 2021, 12-09, Volume: 64, Issue:23

    Topics: Antiviral Agents; Coronavirus 3C Proteases; Humans; Protease Inhibitors

2021